Table 1.
WHO | |||
---|---|---|---|
Drugs | Paucibacillary | Multibacillary | |
Dapsone | Adult | 100 mg daily | 100 mg daily |
Child (10–14 yrs.) | 50 mg | 50 mg | |
Child under 10 | 25 mg | 25 mg | |
Rifampin | Adult | 600 mg once/month | 600 mg once/month |
Child (10–14 yrs.) | 450 mg once/month | 450 mg once/month | |
Child under 10 | 300 mg once/month | 300 mg once/month | |
Clofazimine | Adult | – | 50 mg daily plus 300 mg once/month |
Child (10–14 yrs.) | – | 50 mg daily plus 150 mg once/month | |
Child under 10 | – | 50 mg twice a week and 100 mg once a month | |
Duration (months) | 6 doses (6 blisters) that can be taken until 9 months | 12 doses (12 blisters) that can be taken until 9 months |
In the USA, PB patients are treated with rifampin 600 mg and dapsone 100 mg daily for 12 months. MB patients are treated with rifampin 600 mg, clofazimine 50 mg daily, and dapsone 100 mg for 24 months